GE HealthCare Technologies Inc. (GEHC) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Healthcare Information Services 산업에서 운영. 본사 소재지는 Chicago, IL, 미국. 현재 CEO는 Peter J. Arduini.
GEHC 을(를) 보유 IPO 날짜 2022-12-15, 53,000 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $34.07B.
GE HealthCare Technologies Inc. is a global medical technology company headquartered in Chicago, Illinois, that develops, manufactures, and markets diagnostic imaging systems, patient monitoring solutions, and pharmaceutical contrast agents. Operating through four segments—Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics—the company serves healthcare providers across the United States, Europe, Asia, Africa, and the Middle East. Its Imaging segment offers CT, MR, X-ray, and molecular imaging systems, while its Ultrasound segment provides ultrasound solutions for radiology, cardiology, and point-of-care applications. The Patient Care Solutions segment delivers patient monitoring, anesthesia, respiratory care, and maternal infant care products and services, whereas the Pharmaceutical Diagnostics segment supplies contrast media and radiopharmaceuticals essential for diagnostic imaging procedures. Through its comprehensive portfolio of hardware, software, and digital solutions, GE HealthCare enables clinicians to diagnose, treat, and monitor patients more effectively.
